Millipore Sigma Vibrant Logo

MABN784 Anti-FMR1polyG Antibody, clone 2J7

View Products on Sigmaaldrich.com
MABN784
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWB, IHC, ICCMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABN784
      DescriptionAnti-FMR1polyG Antibody, clone 2J7
      Alternate Names
      • Fragile X mental retardation protein 1 RANT fusion
      • FMR1polyG
      • FMRP RANT fusion
      • FMR-1 RANT fusion
      Background InformationFragile X-associated Tremor/Ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by an elevated CGG-repeat expansions (55-200) in the 5′ UTR of the fragile-X mental retardation 1 gene FMR1 (also known as FRAXA, POF1; Gene ID 2332) on the X-chromosome. The CGG repeat expansion in FXTAS triggers repeat-associated non-ATG-initiated translation (RAN or RANT), also known as repeat-associated non-AUG-initiated translation, within the 5’UTR of FMR1 mRNA, resulting in the production of fusion proteins (FMR1polyG) that contain N-terminal polyglycine fused to either C-terminal FMR1 in-frame sequence or one of two FMR1 frame-shift sequences. Immunohistochemical analysis of FXTAS brain tissues reveals FMR1polyG-positive aggregates that closely resemble neuronal intranuclear inclusions seen in polyglutamine diseases and other protein-mediated neurodegenerative disorders. Much larger expansions of the same repeat cause fragile X syndrome (FRAX), the most common inherited form of mental retardation, by silencing FMR1 transcription.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal IgG2bκ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      Key Applications
      • Western Blotting
      • Immunohistochemistry
      • Immunocytochemistry
      Application NotesImmunohistochemistry Analysis: A representative lot detected FMR1polyG immunoreactivity in paraffin-embedded brain tissue sections from Fragile X-associated Tremor/Ataxia syndrome (FXTAS) patients, but not in brain tissues from non-FXTAS individuals (Todd, P.K., et al. (2013). Neuron. 78(3):440-455).
      Immunohistochemistry Analysis: A representative lot detected both ubiquitinated inclusions-associated and non-inclusions-associated FMR1polyG immunoreactivity by dual fluorescent immunohistochemistry using paraffin-embedded brain tissue sections from Fragile X-associated Tremor/Ataxia syndrome (FXTAS) patients (Todd, P.K., et al. (2013). Neuron. 78(3):440-455).
      Western Blotting Analysis: A representative lot detected recombinant FMRpolyG GST fusion constructs, while only one immunoreactive band (~15 kDa) could be detected in Fragile X-associated Tremor/Ataxia syndrome (FXTAS) patients brain lysates due to extended aggregation of FMR1polyG (Todd, P.K., et al. (2013). Neuron. 78(3):440-455).
      Immunocytochemistry Analysis: A representative lot detected exogenously expressed FLAG-FMR1polyG constructs by fluorescent immunocytochemistry (Todd, P.K., et al. (2013). Neuron. 78(3):440-455).
      Biological Information
      ImmunogenOvalbumin-conjugated linear peptide corresponding to a sequence from the C-terminal region of FMR1polyG.
      EpitopeC-terminal region.
      Clone2J7
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityThis monoclonal antibody does not detect the Fragile X mental retardation protein 1 sequences reported by UniProt (Q06787-1 through Q06787-9). It detects one of the two possible types of FMR1 frame-shift sequences with N-terminal polyG fusion found in Fragile X-associated Tremor/Ataxia syndrome (FXTAS) patients due to CGG repeats expansion (55-200 repeats) in the 5’UTR of the FMR1 gene. Due to the extended aggregation of the pathological forms of FMR1polyG, the detection of FMR1polyG in patient samples by Western blotting is not recommended.
      IsotypeIgG2bκ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Gene Symbol
      • FMR1
      • FRAXA
      • POF1
      Purification MethodProtein G Purified
      UniProt Number
      Molecular WeightVariable, depending on the sizes of the FMR1polyG fusions and aggregates.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in COS GFP-FMRpolyG cells.

      Western Blotting Analysis: 1.0 µg/mL of this antibody detected an exogenously expressed FMR1polyG GFP fusion construct in transfected COS cells.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABN784 04055977311846

      Documentation

      Anti-FMR1polyG Antibody, clone 2J7 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-FMR1polyG Antibody, clone 2J7 Certificates of Analysis

      TitleLot Number
      Anti-FMR1polyG, clone 2J7 - 3386858 3386858
      Anti-FMR1polyG, clone 2J7 - 3776234 3776234
      Anti-FMR1polyG, clone 2J7 -Q2635125 Q2635125
      Anti-FMR1polyG, clone 2J7 Monoclonal Antibody 3030517
      Anti-FMR1polyG, clone 2J7 Monoclonal Antibody 2925948
      Anti-FMR1polyG, clone 2J7 Monoclonal Antibody 2956743

      References

      Reference overviewPub Med ID
      CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.
      Todd, PK; Oh, SY; Krans, A; He, F; Sellier, C; Frazer, M; Renoux, AJ; Chen, KC; Scaglione, KM; Basrur, V; Elenitoba-Johnson, K; Vonsattel, JP; Louis, ED; Sutton, MA; Taylor, JP; Mills, RE; Charlet-Berguerand, N; Paulson, HL
      Neuron  78  440-55  2013

      Show Abstract
      23602499 23602499

      Brochure

      Title
      Neuroscience Solutions for productive research

      Related Products & Applications

      Related Products

      Catalogue Number Description  
      03-108 RIPAb+ Fragile X Mental Retardation Protein - RIP Validated Antibody and Primer Set Show Pricing & Availability
      MAB2160 Anti-Fragile X Mental Retardation Protein Antibody, clone 1C3 Show Pricing & Availability
      MABN1788 Anti-FMR1polyG Antibody, clone 9FM-1B7 Show Pricing & Availability

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies